Amendment to Equity Distribution Agreement between Cocrystal Pharma, Inc. and Alliance Global Partners
Cocrystal Pharma, Inc. and Alliance Global Partners have agreed to amend their existing Equity Distribution Agreement. The amendment clarifies that the termination of the agreement with Barrington Research Associates, Inc. does not affect the validity of the agreement with Alliance Global Partners. Additionally, the agreement with Alliance Global Partners is suspended on an interim basis, with the possibility of resumption upon notice from Cocrystal Pharma. Both parties have signed this amendment to confirm their understanding and acceptance of these changes.
Cocrystal Pharma, Inc.
19805 N. Creek Parkway
Bothell, WA 98011
March 20, 2019
VIA EMAIL: [ ***@***]
Alliance Global Partners /A.G.P
590 Madison Avenue, 36th Floor
New York, New York 10022
RE: Amendment and Submission of Equity Distribution Agreement
Ladies and Gentlemen:
Reference is made to the Equity Distribution Agreement entered into with you and certain other broker-dealers on July 19, 2018 (the “Agreement”). In connection with the terminating of the Agreement with Barrington Research Associates, Inc. (“Barrington”) and suspending the Agreement as to Alliance Global Partners (“AGP”), Cocrystal Pharma, Inc. (the “Company”) and AGP each agree to amend the Agreement in order to provide that the termination under Section 11(b) of the Agreement as to Barrington shall not affect the validity of the Agreement and that the suspension by the Company shall be on an interim basis until such later date as the Company may give notice to AGP.
Please execute a copy of this letter agreement indicating that the Agreement shall be amended.
Sincerely yours, | |
COCRYSTAL PHARMA, INC. |
By: | /s/ James Martin | |
James Martin | ||
Chief Financial Officer |
Alliance Global Partners//A.G.P
March 20, 2019
Page 2
We hereby agree to the foregoing:
Alliance Global Partners//A.G.P
By: | /s/ Thomas J. Higgins | |
Thomas J. Higgins | ||
Managing Director, Investment Banking |
cc: | Mr. Gary Wilcox (via email) | |
Michael D. Harris, Esq. (via email) |